Appendix_2_GLeblanc – Supplemental material for Incidence and impact of withdrawal of life-sustaining therapies in clinical trials of severe traumatic brain injury: A systematic review Guillaume Leblanc Amélie Boutin Michèle Shemilt François Lauzier Lynne Moore Véronique Potvin Ryan Zarychanski Patrick Archambault François Lamontagne Caroline Léger Alexis F Turgeon 10.25384/SAGE.6820730.v1 https://sage.figshare.com/articles/journal_contribution/Appendix_2_GLeblanc_Supplemental_material_for_Incidence_and_impact_of_withdrawal__of_life-sustaining_therapies_in_clinical_trials_of_severe_traumatic_brain_injury_A__systematic_review/6820730 <p>Supplemental material, Appendix_2_GLeblanc for Incidence and impact of withdrawal of life-sustaining therapies in clinical trials of severe traumatic brain injury: A systematic review by Guillaume Leblanc, Amélie Boutin, Michèle Shemilt, François Lauzier, Lynne Moore, Véronique Potvin, Ryan Zarychanski, Patrick Archambault, François Lamontagne, Caroline Léger and Alexis F Turgeon in Clinical Trials</p> 2018-06-04 12:00:00 Brain injury clinical trial life-sustaining therapy end-of-life